Subscribe by Email

About the Blog

The Active Ingredient features expert insights and commentary from leaders of ZS Associates' global pharmaceuticals practice.

Search by Topic

see all

The Keys to Pharma’s AI Success Include ‘Disruptive Collaborations’ and a Willingness to Innovate and Iterate

Posted by Pratap Khedkar on Wed, Jan 24, 2018

This is the final post in a three-part series on artificial intelligence in healthcare. 

Of all of the marketplace dynamics and advances currently posing a threat to pharma’s traditional methods and models, artificial intelligence and advanced data science are causing their fair share of consternation. I recently addressed this issue with my colleague John Piccone, a ZS principal and advanced data science expert who previously led IBM Watson Health’s life sciences offerings, and he succinctly stated the commercial transformation challenge that lies ahead: “Pharma’s role is going to change from educating people to educating algorithms.” How can pharma get there? What steps can companies start taking now to adapt? John has some ideas.

Read More

Topics: patient outcomes, outcomes, artificial intelligence, commercial strategy, pharma companies, artificial intelligence & pharma, educate algorithms, innovators, traditional model, AI blog series

Subscribe to The Active Ingredient
SUBSCRIBE

Get 'THE ACTIVE INGREDIENT' Updates

Subscribe to receive email notifications whenever new blog posts are published.

×